<DOC>
	<DOCNO>NCT00595491</DOCNO>
	<brief_summary>Asthma heterogeneous disorder multiple potential inflammatory pathway contribute airway obstruction . The biological basis airway inflammation subject intensive investigation . This work design identify airway factor responsible recruit cell associate airway presence atopy asthma .</brief_summary>
	<brief_title>Pilot Study Identify Mediators Inflammatory Cell Surface Receptors Involved Allergic Airway Inflammation</brief_title>
	<detailed_description>The production chemotactic cytokine chemokines airways one mechanism think responsible recruitment inflammatory cell airway ( Makay 2001 ) . While chemokine receptor-ligand system responsible immune cell home mucosal surface gastrointestinal tract clarify , responsible allergic airway inflammation remain unknown . This work design identify airway factor responsible recruit cell associate airway presence atopy asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>A . Subjects Allergic Asthma ( AA subject ) 1 . All subject baseline FEV1 determine characterization visit le 75 % predict value . 2 . All subject clinical history allergic symptom cat dust mite allergen demonstrate skin reactivity ( positive allergen prick test ) . 3 . Lifelong absence cigarette smoking ( define lifetime total less 5 packyears ) ; none 5 year ) . 4 . Willing able give inform consent . 5 . Expressed desire participate interview principal investigator . 6 . Age 18 50 year . 1 . Women childbearing potential document pregnant ( base Urine betaHCG test ) , sexually active use contraception , seek become pregnant , nursing . 2 . The presence spontaneous asthmatic episode clinical evidence upper respiratory tract infection within previous 6 week . 3 . Participation research study involve drug biologic 30 day prior study . 4 . Intolerance albuterol , atropine , lidocaine , fentanyl , midazolam . 5 . Antihistamines within 7 day screen visit . 6 . Presence diabetes mellitus , congestive heart failure , ventricular arrhythmia , history cerebrovascular accident , renal failure , history anaphylaxis , cirrhosis . 7 . Use systemic steroid , increase use inhaled steroid , beta blocker MAO inhibitor visit asthma exacerbation within 1 month screen visit . 8 . Antibiotic use respiratory disease within 1 month characterization visit respiratory tract infection within 6 week bronchoscopy visit . 9 . A history asthmarelated respiratory failure require intubation . 10 . Quantitative skinprick test positive reaction allergen concentration 0.056 BAU AU/ml . 11 . Taking betaadrenergic block agent monoamine oxidase inhibitor . 12 . Subjects high possibility poor compliance study . 13 . No history cigarette smoking within past 5 year &gt; 10 pack year total . 14 . Having secondhand cigarette smoke exposure indoor furry pet except case dog , subject allergic dog subject negative skin test dog ( It also prefer require dust mite allergic subject dust miteproof encasings mattress pillow . ) 15 . Other lung disease , sarcoidosis , bronchiectasis active lung infection . 16 . Use Xolair ( omalizumab antiIgE monoclonal antibody ) 6 month . 17 . Immunotherapy cat dust mite extract past . 18 . NonEnglish speaker . 19 . History coagulopathy , thrombocytopenia , pulmonary hypertension , and/or use anticoagulants/antiplatelet drug . B . Healthy Normal Control Subjects ( NC subject ) Normal control subject individual good overall health , age sex match asthmatic group , age 18 50 nonallergic , i.e . entirely negative panel prick skin test list section V ( Study Procedures ) , history allergic rhinitis asthma , history allergic symptom cause cat dust mite allergen exposure , lifelong nonsmoker cigarette ( define lifetime total less 5 packyears none 5 year ) , normal spirometry ( i.e . FEV1 FVC least 90 % predict ) methacholine PC20 &gt; 16 mg/ml . 1 . A history allergy , asthma , nasal sinus disease . 2 . Exclusion criterion # 1 , 38 1019 ( A . ) . C. Allergic Nonasthmatic Subjects ( ANA subject ) 1 . ANA subject history either ( ) allergic rhinitis ( one follow symptom : nasal congestion , sneeze , runny nose , postnasal drainage ) , ( b ) allergic conjunctivitis ( ocular itching , tear and/or swell ) ( c ) contact allergy associate cat dander dust mite positive allergy test allergen . 2 . All subject baseline FEV1 FVC determine characterization visit le 90 % predict value . 3 . All subject positive allergy skin prick test cat dander dust mite allergen . 4 . All subject good general health . 5 . Lifelong absence cigarette smoking ( define lifetime total less 5 packyears none 5 year ) . 6 . Willing able give inform consent . 7 . Expressed desire participate interview principal investigator . 8 . Age 18 50 year . 1 . A history asthma . 2 . Exclusion criterion # 1 , 38 1019 ( A . ) . 3 . A methacholine PC20 &lt; 16 mg/ml .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Allergic</keyword>
	<keyword>Airway</keyword>
	<keyword>Challenge</keyword>
	<keyword>Chemokines</keyword>
</DOC>